Out Of Stock
SKU
RETEVAL-001

RETeval-DR Electroretinograph

Please contact the Welch Allyn Malaysia office for device price
RM 29,500.00

The Welch Allyn RETeval-DR Electroretinograph is designed for healthcare providers who want to improve management of their patients with diabetes. In just three minutes, you can objectively screen for vision-threatening diabetic retinopathy (VTDR) wherever patients receive care. Welch Allyn RETeval-DR Electroretinograph enables efficient, comfortable, non-mydriatic screening for VTDR that improves patient compliance to help preserve vision in your patients with diabetes.

Features

  • No dilation required, enhancing patient comfort
  • Short test time-only three minutes per patient
  • No interpretation and minimal training necessary
  • Immediate results provided on the device and in a PDF report
  • Portable, handheld device goes wherever patients with diabetes receive care

RETeval-DR is designed for healthcare providers who want to improve management of their patients with diabetes.

RETeval-DR can safely identify patients at low risk for blindness from diabetic retinopathy with 99.2% negative predictive value*, thereby allowing eye care providers to focus more time on patients with vision-threatening diabetic retinopathy.

 

Download Brochure

More Information
Item Returns This item can be returned
Write Your Own Review
You're reviewing:RETeval-DR Electroretinograph
Your Rating